Labiotech.eu

Interview 27 Feb 2017

Meet the Woman developing the Next Generation of Insulin

Fiasp, ultra-fast-acting insulin, could revolutionize insulin. We chatted with Liselotte Hyveled, the woman heading the team behind it. “I didn’t get into nursing school, so I went into pharmacy instead,” Liselotte Hyveled laughs. “In Denmark, we have free education, but the government limits degrees for students based on job market needs. There was a low […]

February 27, 2017 - 7 minutesmins - By Evelyn Warner

BOM Gallery Laurie Ramsell Gina Czarnecki

News and Trends 25 Feb 2017

Art Made with Human DNA Explores the Future of Genetics in Birmingham

Gene Craft: Art in the Biogenetic Age opened this week at Birmingham Open Media (BOM) in the UK. Aiming to explore the social, economic and emotional implications of the most recent breakthroughs in genetics, the exhibition features two living art pieces created with human DNA by bioartists Laurie Ramsell and Gina Czarnecki. After the Human Fertilisation and Embryology Authority (HFEA) […]

February 25, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

bidirectional neuroprosthesis university of geneva unige

More News! 24 Feb 2017

Interfacing the Brain & Machines: Another Step to a Cyborg Future

Controlling robotic prostheses with one’s mind has been a hot topic in research, but making a prothesis ‘talk back’ has been a stumbling block. Researchers from Switzerland show progress in creating sensations from a bidirectional neuroprosthesis. Researchers from the University of Geneva, in Switzerland, are developing a new method to connect a prosthesis to neural activity […]

February 24, 2017 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 24 Feb 2017

What are the Current Challenges in the Booming Field of ADCs?

ADCs are overcoming the challenges of first generations and returning with a vengeance. I attended the World ADC Conference to hear about current efforts. ADCs represent an exciting new field that has seen renewed interest in the past few months, as funding has poured into NBE Therapeutics and ADC Therapeutics. Theses drugs are overcoming the challenges that held the first two generations back […]

February 24, 2017 - 5 minutesmins - By Evelyn Warner

News and Trends 23 Feb 2017

In the Age of Biological Therapeutics, Chemists move to ADCs

Career options for chemists are shrinking in the shift towards biological drugs. But as antibody-drug conjugates (ADCs) take off, so do opportunities for chemists! Since I quit graduate school in chemistry research and dove into biotech journalism, I wasn’t sure when I would next enter a discussion about organic synthesis. This week, less than a year after […]

February 23, 2017 - 4 minutesmins - By Evelyn Warner

News and Trends 23 Feb 2017

Biosimilars set to take on Oncology after a new Market Authorization

The European Commission has approved Truxima, the world’s first biosimilar monoclonal antibody (mAb) with an oncology indication. Based in South Korea, Celltrion Healthcare is setting foot in the European oncology market with the approval of Truxima, a biosimilar to Roche’s Mabthera (rituximab). The European Commission has approved the antibody for non-Hodgkin’s lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis […]

February 23, 2017 - 3 minutesmins - By Melanie De Almeida

News and Trends 23 Feb 2017

NGS Metagenomics Test could Curb Antibiotic-Resistant Infections

PathoQuest has shown its metagenomics sequencing technology can identify more pathogens in immunocompromised patients than the standard procedures, keeping antibiotic-resistant infections at bay. PathoQuest, a spin-off from the Institut Pasteur in Paris, develops next-generation sequencing (NGS) metagenomics tests. The company just announced the publication of results from a clinical trial comparing its iDTECT Blood technology […]

February 23, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 23 Feb 2017

Reach for the BioStars! Meet the Top 3 Biotech Startups from Oxford

A new round of this young startup competition is underway! What is this Oxford-based competition, and who competes? We talked to previous participants. BioStars is a flagship startups booster run by a group of PhDs, MBA and post-docs, who dedicate their spare time to enabling bio-entrepreneurs to turn their scientific ideas into actual products. Brought […]

February 23, 2017 - 5 minutesmins - By External Contributor

Apollo Therapeutics drug discovery launch

News and Trends 22 Feb 2017

UK’s Joint Venture Bridging Academia and Industry is Ready for Kick Off

Apollo Therapeutics is a UK-based joint venture bridging academia and industry to drive the translation of university research. Its first four drug discovery programmes will now be launched. Apollo Therapeutics was founded in early 2016 as a collaborative effort of the three global pharmaceutical companies, AstraZeneca, GlaxoSmithKline and Johnson & Johnson Innovation, and the world-leading UK-universities, Imperial College London, UCL and the University of […]

February 22, 2017 - 2 minutesmins - By Melanie De Almeida

News and Trends 22 Feb 2017

Roche doubles down in Fight against Antibiotic Resistance

In 2014, Discuva partnered up with Roche to develop new antibiotics against multidrug-resistant bacteria. The two companies have announced an extension of their collaboration until February 2018. The Cambridge-based company Discuva wants to address the critical need for new antibiotic drugs to treat infections from multidrug-resistant bacteria. Posing a major public health threat, antibiotic resistances cause at least 25,000 deaths per year in […]

February 22, 2017 - 2 minutesmins - By Melanie De Almeida

News and Trends 22 Feb 2017

Meet these 5 Awesome Biotechs from Barcelona at BIO Europe Spring 2017

As BIO Europe Spring 2017 approaches, we decided to take a closer look into biotechs from Barcelona, one of the hottest biotech hubs in Europe. Spring is coming and with it a new edition of BIO Europe Spring that will take place by the beach in Barcelona. The city has established itself as a hub for life sciences within […]

February 22, 2017 - 5 minutesmins - By External Contributor

Apitope Multiple Sclerosis ATX MS 1467 phase IIa 1

News and Trends 21 Feb 2017

A New Peptide Vaccine for Multiple Sclerosis Succeeds in Phase IIa

Apitope is developing therapeutic peptides to induce suppression of autoimmune responses towards self-antigens. Their recent phase IIa trial has revealed promising results for the treatment of multiple sclerosis. Multiple sclerosis (MS) is a hot topic these days. While a recent long-term study revealed the potential of hematopoietic stem cell transplantation for the treatment of MS, this treatment strategy is […]

February 21, 2017 - 3 minutesmins - By Melanie De Almeida

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Meet the Woman developing the Next Generation of Insulin

Art Made with Human DNA Explores the Future of Genetics in Birmingham

Interfacing the Brain & Machines: Another Step to a Cyborg Future

What are the Current Challenges in the Booming Field of ADCs?

In the Age of Biological Therapeutics, Chemists move to ADCs

Biosimilars set to take on Oncology after a new Market Authorization

NGS Metagenomics Test could Curb Antibiotic-Resistant Infections

Reach for the BioStars! Meet the Top 3 Biotech Startups from Oxford

UK’s Joint Venture Bridging Academia and Industry is Ready for Kick Off

Roche doubles down in Fight against Antibiotic Resistance

Meet these 5 Awesome Biotechs from Barcelona at BIO Europe Spring 2017

A New Peptide Vaccine for Multiple Sclerosis Succeeds in Phase IIa

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!